What we’ve been reading: Week of May 18, 2015


From cancer to feet: the power of Twitter in healthcare (MedCity News)
Why does Twitter care about the healthcare industry? Craig Hashi, one of two Twitter engineers dedicated to healthcare, details the opportunities.

MIT’s implantable device could help docs determine best cancer medicine (Boston Business Journal)
Removing the trial and error associated with cancer drug treatments is high on oncologists’ wish lists. Heeding that call, MIT has developed an implantable device (about the size of a grain of rice) that can carry up to 30 different drug doses to a cancerous tumor, and then be removed to test responses.

Scientists are growing anxious about genome-editing tools (Washington Post)
CRISPR/Cas9 and targeted genome editing: Is it too much too soon?

Amputees control bionic legs with their thoughts (Science Daily)
Mind over mechanics. Mind-bending technology interfaces with the brain, allowing amputees to mentally control their bionic prosthetic limbs.

Antibiotics Resurface as Alternative to Removing Appendix (New York Times)
Surgery or meds? According to a recent study published in The New England Journal of Medicine, antibiotics are a potential alternative to an appendectomy.

Good looking: How time outdoors could protect kids’ eyesight (New Scientist)
Carrots aren’t the only way to improve eyesight. Studies suggest more outdoor time may impact shortsightedness. (Subscription required)

Nurse Reflects on Tour Treating Ebola Patients in Sierra Leone (New York Times)
Thirty-one-year-old New York nurse Lindsey Hallen was drawn to the front lines of the Ebola epidemic. Before embarking on her mission, she had to make a choice: treat patients in Sierra Leone or commit herself to infrastructure building in Liberia. She chose direct patient care.